Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹43.2 Cr -15.2% -41.4% -58.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹5,874.7 Cr -1.7% -16.3% -22.8% Stock Analytics
KIRI INDUSTRIES ₹2,021.6 Cr -6.1% -25.8% -44% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,365.5 Cr 2.2% -10.1% -40.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹975.3 Cr 9.5% -4.1% 5.3% Stock Analytics
BODAL CHEMICALS ₹645.3 Cr -10% 9.1% -13.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-15.2%

-41.4%

-58.4%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses